Big Pharma’s health-care extortion

Robert Reich

Salon.com

The White House has already sold out to Big Pharma, said Robert Reich. In return for drug-industry support for its health-care plan, the Obama administration admitted this week that it had privately promised the industry that any legislation passed would explicitly prohibit the government from using its huge purchasing power to lower drug prices.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

This is basically an extension of the corrupt deal the industry struck with President Bush, which expanded the drug benefits available through Medicare, producing “a bonanza” of billions for drug-makers. Big Pharma, which has budgeted $150 million for TV ads promoting Obama’s reform, has vaguely promised to cut future drug costs by $80 billion. But no one seems able to pinpoint where the savings will come from, and they may never be realized.

As a member of the Clinton administration, I watched Pharma and its allies kill health-care reform in 1994, so I understand the value of bringing such a powerful special interest on board. But when the White House feels it cannot bring about reform without making “secret concessions” that will hurt consumers and taxpayers, it’s a sign that “our democracy is in terrible shape.”